Constantijn J M Halkes

10PUBLICATIONS
79CO-AUTHORS
HaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 19, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE Study.

|Jan 22, 2026
Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry.

C J M Halkes, E A S Koster, E J M Bogers

|Oct 20, 2025
Transplantation strategy affects the risk of GvHD after prophylactic and preemptive donor lymphocyte infusion.

Eva A S Koster, Peter A von dem Borne, Joost G K van der Hem

|Apr 21, 2024
Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT.

Juan Montoro, Dirk-Jan Eikema, Joe Tuffnell

|Mar 01, 2024
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.

Kyra J Fuchs, Marian van de Meent, M Willy Honders

|Nov 13, 2022
SARS-CoV-2 mRNA vaccination of aplastic anemia patients is safe and effective.

Cilia R Pothast, Kayleigh van Dijk, Emma S Pool

Pageof 2

Frequent Collaborators

3 joint publications

Eva A S Koster

3 joint publications

Jennifer M L Tjon

3 joint publications

Liesbeth C de Wreede

3 joint publications

Antonio Risitano